Clinical Trial Update: Next Generation Personalized Neuroblastoma Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial of next-generation personalized neuroblastoma therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Yael P Mosse | Conditions: Neuroblastoma, Cancer | Phase 1 | Status: TERMINATED